Clinical Trial Update: Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK) [NA]

View source ↗

Summary

An ongoing trial comparing air versus SF6 gas in Descemet's Membrane Endothelial Keratoplasty (DMEK) for Fuchs' Endothelial Dystrophy and Bullous Keratopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Keratopathy
• Fuchs Endothelial Dystrophy

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Fuchs' Endothelial Dystrophy, Bullous Keratopathy | NA | Status: UNKNOWN